The authors reported that BDNF levels measured during the acute stroke phase in patients with poor outcome (mRS = 3–6) were lower compared to those with good outcome (p < 0.001) and that BDNF was an independent stroke outcome predictor. This evidence concerns the gene BDNF and stroke disorder.